(Q36901969)

17 August 2017

1 reference

title

Etiological treatment of chronic Chagas disease: neglected 'evidence' by evidence-based medicine (English)

1 reference

17 August 2017

0 references

evidence-based medicine

1 reference

Rodolfo Viotti

1

1 reference

PubMed ID

17678432

17 August 2017

Carlos Vigliano

series ordinal

2

1 reference

17 August 2017

1 August 2007

1 reference

Expert Review of Anti-infective Therapy

17 August 2017

1 reference

17 August 2017

5

1 reference

17 August 2017

4

1 reference

17 August 2017

717-726

1 reference

Evidence based medicine: what it is and what it isn't

17 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.717

Evidence based policymaking

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.717

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.717

Limitations of "pragmatic" trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.717

Pathogenesis of chronic Chagas heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.717

Correlation between Trypanosoma cruzi parasitism and myocardial inflammatory infiltrate in human chronic chagasic myocarditis: Light microscopy and immunohistochemical findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.717

Trypanosoma Cruzi-Induced Host Immune System Dysfunction: A Rationale for Parasite Immunosuppressive Factor(s) Encoding Gene Targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.717

Trypanosoma cruzi in persons without serologic evidence of disease, Argentina

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.717

Idiopathic dilated cardiomyopathy as a late complication of healed viral (Coxsackie B virus) myocarditis: historical analysis, review of the literature, and a postulated unifying hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.717

Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.717

Immunization with recombinant Trypanosoma cruzi ribosomal P2beta protein induces changes in the electrocardiogram of immunized mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.717

Humoral autoimmune response to ribosomal P proteins in chronic Chagas heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.717

Autoimmunity in Chagas disease cardiopathy: biological relevance of a cardiac myosin-specific epitope crossreactive to an immunodominant Trypanosoma cruzi antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.717

Pathophysiological insights into the cardiomyopathy of Chagas' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.717

Where do we stand on the autoimmunity hypothesis of Chagas disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.717

Pathophysiology of the heart in Chagas' disease: current status and new developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.717

Parasite persistence in the aetiology of Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.717

Generation, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.717

Risk progression to chronic Chagas cardiomyopathy: influence of male sex and of parasitaemia detected by polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.717

Parasite persistence correlates with disease severity and localization in chronic Chagas' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.717

The frequency and prognostic significance of electrocardiographic abnormalities in clinically normal individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.717

Value of echocardiography for diagnosis and prognosis of chronic Chagas disease cardiomyopathy without heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.717

Ventricular tachycardia during exercise testing as a predictor of sudden death in patients with chronic chagasic cardiomyopathy and ventricular arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.717

Exercise stress testing as a predictor of progression of early chronic Chagas heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.717

Predictors of mortality in chronic Chagas disease: a systematic review of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.717

Clinical predictors of chronic chagasic myocarditis progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.717

Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.717

Modulation of autoimmunity by treatment of an infectious disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.717

New evidence of spontaneous cure in human Chagas' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.717

Congenital transmission of Trypanosoma cruzi infection in Argentina

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.717

Congenital transmission of Trypanosoma cruzi is associated with maternal enhanced parasitemia and decreased production of interferon- gamma in response to parasite antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.717

The validity of serologic tests for Trypanosoma cruzi and the effectiveness of transfusional screening strategies in a hyperendemic region

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.717

Specific chemotherapy of Chagas disease: controversies and advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.717

The Anti-Trypanosoma cruzi activity of posaconazole in a murine model of acute Chagas' disease is less dependent on gamma interferon than that of benznidazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.717

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.717

In vivo detection of Trypanosoma cruzi antigens in hearts of patients with chronic Chagas' heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.717

Manifestations of Chagas disease (American trypanosomiasis) in patients with HIV/AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.717

21 January 2018

Identifiers

DOI

10.1586/14787210.5.4.717

1 reference

17 August 2017

1 reference

PubMed ID

17678432